TargeTech Inc. on Monday named Henry L. Nordhoff presidentand chief executive officer. He had been president and CEO ofAmerican Biogenetic Sciences Inc. Meriden, Conn.-basedTargeTech is developing and commercializing injectable genetherapies based on its receptor-targeting technology.

(c) 1997 American Health Consultants. All rights reserved.